Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, September 24, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
FDA Grants Priority Review to ENHERTU and Pertuzumab Combination for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Life Sciences Times
-
September 24, 2025
Pharma
Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-1230 for KCNT1-Related Epilepsy
Life Sciences Times
-
September 23, 2025
Pharma
FDA Issues Complete Response Letter for Scholar Rock’s Apitegromab, Citing Catalent Facility Observations
Life Sciences Times
-
September 23, 2025
Pharma
Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine
Life Sciences Times
-
September 23, 2025
Pharma
KalVista Wins EU, Swiss Approvals for EKTERLY, First Oral On-Demand Therapy for Hereditary Angioedema
Life Sciences Times
-
September 19, 2025
Pharma
Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon...
Life Sciences Times
-
January 10, 2023
0
Pharma
HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603
Life Sciences Times
-
January 9, 2023
0
Pharma
Myrtelle Announces Positive Interim Data in Phase 1/2 Clinical Trial of Its Proprietary Investigational Gene Therapy rAAV-Olig001-ASPA in Canavan Disease
Life Sciences Times
-
January 9, 2023
0
Pharma
Glycomine Announces First Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential Treatment for PMM2-CDG
Life Sciences Times
-
January 9, 2023
0
Pharma
Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1
Life Sciences Times
-
January 9, 2023
0
Pharma
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in Mantle Cell Lymphoma
Life Sciences Times
-
January 5, 2023
0
Pharma
PharmaEssentia Establishes a New Research and Development Facility in the Boston Area
Life Sciences Times
-
January 4, 2023
0
Pharma
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Life Sciences Times
-
January 3, 2023
0
Pharma
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting
Life Sciences Times
-
December 22, 2022
0
Pharma
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes
Life Sciences Times
-
December 21, 2022
0
Pharma
ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Life Sciences Times
-
December 21, 2022
0
Pharma
Seagen, Astellas and Merck Announce FDA Acceptance of sBLAs for PADCEV® with KEYTRUDA® for the First-Line Treatment of Certain Patients With Locally Advanced or...
Life Sciences Times
-
December 20, 2022
0
1
...
32
33
34
...
80
Page 33 of 80
Most Read
Future Family Names Alden Romney CEO, Founder Claire Tomkins Transitions to Executive Chair
September 24, 2025
Groups Names Cooper Zelnick as CEO to Lead Next Phase of Growth in Value-Based Addiction Care
September 24, 2025
MEDiC Life Sciences Acquires Clinical-Stage Oncology Program, Leveraging Biomarker Platform for Precision Medicine
September 24, 2025
AVS Expands with New Waltham Headquarters as It Prepares for U.S. Launch of PULSE IVL System
September 24, 2025